Practice guidelines for perioperative blood management: An updated report by the american society of anesthesiologists task force on perioperative blood management

Anesthesiology

Volumn 122, Issue 2, 2015, Pages 241-275

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; DESMOPRESSIN; HEMOSTATIC AGENT; PROTHROMBIN COMPLEX; TRANEXAMIC ACID;

ANEMIA; ANESTHESIST; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD DONOR; BLOOD TRANSFUSION; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; HEMODILUTION; HUMAN; HYPOFIBRINOGENEMIA; INTRAOPERATIVE PERIOD; LEUKAPHERESIS; MEDICAL SOCIETY; OPERATIVE BLOOD LOSS; ORGAN PERFUSION; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; STANDARDS;

BLOOD TRANSFUSION; EVIDENCE-BASED MEDICINE; HUMANS; PERIOPERATIVE CARE;

EID: 84925348610     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000463     Document Type: Review

References (277)

1. Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on blood transfusion and adjuvant therapies. Anesthesiology 2006; 105:198-208
2. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT,Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN: 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; [Epub ahead of print]
3. Ferraris VA, Ferraris SP, Saha SP, Hessel EA 2nd, Haan CK, Royston BD, Bridges CR, Higgins RS, Despotis G, Brown JR, Spiess BD, Shore-Lesserson L, Stafford-Smith M, Mazer CD, Bennett-Guerrero E, Hill SE, Body S: Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83:S27-86
4. Carson JL, Carless PS, Hebert PC: Transfusion thresholds and other strategies for guiding allogeneic red blood transfusion. Cochrane Database Syst Rev 2012; 4:CD002042
5. Benoist S, Panis Y, Pannegeon V, Alves A, Valleur P: Predictive factors for perioperative blood transfusions in rectal resection for cancer: A multivariate analysis of a group of 212 patients. Surgery 2001; 129:433-9
6. Bjessmo S, Ivert T: Blood loss after coronary artery bypass surgery: Relations to patient variables and antithrombotic treatment. Scand Cardiovasc J 2000; 34:438-45
7. Bocchieri KA, Scheinerman SJ, Graver LM: Exchange transfusion before cardiopulmonary bypass in sickle cell disease. Ann Thorac Surg 2010; 90:323-4
8. Cash KL, Brown T, Sausais L, Uehlinger J, Reed LJ: Severe delayed hemolytic transfusion reaction secondary to anti-At(a). Transfusion 1999; 39:834-7
9. De Santo LS, Amarelli C, Della Corte A, Scardone M, Bancone C, Carozza A, Grassia MG, Romano G: Blood transfusion after on-pump coronary artery bypass grafting: Focus on modifiable risk factors. Eur J Cardiothorac Surg 2013; 43:359-66
10. E ngström KG, Appelblad M, Brorsson B: Mechanisms behind operating room blood transfusions in coronary artery bypass graft surgery patients with insignificant bleeding. J Cardiothorac Vasc Anesth 2002; 16:539-44
11. Fox JS, Amaranath L, Hoeltge GA, Andrish JT: Autologous blood transfusion and intraoperative cell salvage in a patient with homozygous sickle cell disease. Cleve Clin J Med 1994; 61:137-40
12. G audino M, Luciani N, Piancone FL, Bruno P, Rossi M, Schiavello R, Possati G: Perioperative management of a patient with Werlhof disease undergoing myocardial revascularization. J Cardiovasc Surg (Torino) 1999; 40:227-8
13. G errah R, Shargal Y, Elami A: Impaired oxygenation and increased hemolysis after cardiopulmonary bypass in patients with glucose-6-phosphate dehydrogenase deficiency. Ann Thorac Surg 2003; 76:523-7
14. H endriks HG, van der Meer J, Klompmaker IJ, Choudhury N, Hagenaars JA, Porte RJ, de Kam PJ, Slooff MJ, de Wolf JT: Blood loss in orthotopic liver transplantation: A retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis 2000; 11(suppl 1):S87-93
15. Katz K, Tamary H, Lahav J, Soudry M, Cohen IJ: Increased operative bleeding during orthopaedic surgery in patients with type I Gaucher disease and bone involvement. Bull Hosp Jt Dis 1999; 58:188-90
16. L indgren L, Yli-Hankala A, Halme L, Koskimies S, Orko R: Transfusion-related acute lung injury (TRALI ) after fresh frozen plasma in a patient with coagulopathy. Acta Anaesthesiol Scand 1996; 40:641-4
17. L ison S, Spannagl M, Dietrich W; Working Group of Perioperative Hemostasis: Hemophilia A in cardiac operations: A model of reduced thrombin generation. Ann Thorac Surg 2011; 91:1606-8
18. Netzer G, Shah CV, Iwashyna TJ, Lanken PN, Finkel B, Fuchs B, Guo W, Christie JD: Association of RBC transfusion with mortality in patients with acute lung injury. Chest 2007; 132:1116-23
19. Pagani FD, Polito RJ, Bolling SF: Mitral valve reconstruction in sickle cell disease. Ann Thorac Surg 1996; 61:1841-3
20. Potter PS, Waters JH, Burger GA, Mraović B: Application of cell-salvage during cesarean section. Anesthesiology 1999; 90:619-21
21. S utton SW, Hunley EK, Duncan MA, Rodriguez R, Meyers TP: Sickle cell disease and aortic valve replacement: Use of cardiopulmonary bypass, partial exchange transfusion, platelet sequestration, and continuous hemofiltration. Tex Heart Inst J 1999; 26:283-8
22. Uen WC, Chou YH, Liu CC, Lin SM, Chen TJ: Successful resection of sigmoid colon cancer in a patient with factor XI deficiency. J Formos Med Assoc 1998; 97:283-5
23. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M, Ohene-Frempong K, Iyer RV: A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995; 333:206-13
24. Walsh TS, Palmer J, Watson D, Biggin K, Seretny M, Davidson H, Harkness M, Hay A: Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. Br J Anaesth 2012; 108:63-71
25. Karkouti K, Wijeysundera DN, Beattie WS; Reducing Bleeding in Cardiac Surgery (RBC) Investigators: Risk associated with preoperative anemia in cardiac surgery: A multicenter cohort study. Circulation 2008; 117:478-84
26. Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Chan CT, Wong PY, Beattie WS: Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients. Anesthesiology 2011; 115:523-30
27. Kohli N, Mallipeddi PK, Neff JM, Sze EH, Roat TW: Routine hematocrit after elective gynecologic surgery. Obstet Gynecol 2000; 95(6 pt 1):847-50
28. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA, Moehnle P, Mangano DT; Investigators of the Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation: Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007; 116:471-9
29. L e Roux PD, Elliott JP, Winn HR: Blood transfusion during aneurysm surgery. Neurosurgery 2001; 49:1068-74
30. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR: Preoperative anaemia and postoperative outcomes in non-cardiac surgery: A retrospective cohort study. Lancet 2011; 378:1396-407
31. Pirat A, Sargin D, Torgay A, Arslan G: Identification of preoperative predictors of intraoperative blood transfusion requirement in orthotopic liver transplantation. Transplant Proc 2002; 34:2153-5
32. Williams GD, Bratton SL, Riley EC, Ramamoorthy C: Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1999; 13:398-404
33. Brener SJ, Bhatt DL, Moliterno DJ, Schneider JP, Ellis SG, Topol EJ: Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation. Am J Cardiol 2003; 92:1468-71
34. Despotis GJ, Levine V, Filos KS, Santoro SA, Joist JH, Spitznagel E, Goodnough LT : Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology 1996; 85:1311-23
35. E reth MH, Nuttall GA, Klindworth JT, MacVeigh I, Santrach PJ, Orszulak TA, Harmsen WS, Oliver WC Jr: Does the platelet-activated clotting test (HemoST ATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass? Anesth Analg 1997; 85:259-64
36. E reth MH, Nuttall GA, Santrach PJ, Klindworth JT, Oliver WC Jr, Schaff HV: The relation between the platelet-activated clotting test (HemoST ATUS) and blood loss after cardiopulmonary bypass. Anesthesiology 1998; 88:962-9
37. G elb AB, Roth RI, Levin J, London MJ, Noall RA, Hauck WW, Cloutier M, Verrier E, Mangano DT: Changes in blood coagulation during and following cardiopulmonary bypass: Lack of correlation with clinical bleeding. Am J Clin Pathol 1996; 106:87-99
38. G ravlee GP, Arora S, Lavender SW, Mills SA, Hudspeth AS, Cordell AR, James RL, Brockschmidt JK, Stuart JJ: Predictive value of blood clotting tests in cardiac surgical patients. Ann Thorac Surg 1994; 58:216-21
39. H orlocker TT, Nuttall GA, Dekutoski MB, Bryant SC: The accuracy of coagulation tests during spinal fusion and instrumentation. Anesth Analg 2001; 93:33-8
40. Karkouti K, McCluskey SA, Syed S, Pazaratz C, Poonawala H, Crowther MA: The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: A prospective observational study. Anesth Analg 2010; 110:1533-40
41. Murray D, Pennell B, Olson J: Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding. Transfusion 1999; 39:56-62
42. Myers ER, Clarke-Pearson DL, Olt GJ, Soper JT, Berchuck A: Preoperative coagulation testing on a gynecologic oncology service. Obstet Gynecol 1994; 83:438-44
43. Nuttall GA, Oliver WC, Beynen FM, Santrach PJ, Strickland RA, Murray MJ: Determination of normal versus abnormal activated partial thromboplastin time and prothrombin time after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1995; 9:355-61
44. Nuttall GA, Oliver WC, Ereth MH, Santrach PJ: Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11:815-23
45. Reich DL, Yanakakis MJ, Vela-Cantos FP, DePerio M, Jacobs E: Comparison of bedside coagulation monitoring tests with standard laboratory tests in patients after cardiac surgery. Anesth Analg 1999; 88:312-9
46. World Health Organization. Iron deficiency anaemia: Assessment, prevention, and control. A guide for programme managers. World Health Organization 2001
47. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. Edited by de Benoist B, McLean E, Egli I, and Cogswell M. http://whqlibdoc.who.int/publications/ 2008/9789241596657-eng.pdf
48. de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC: Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop (Belle Mead NJ) 1996; 25:533-42
49. de Pree C, Mermillod B, Hoffmeyer P, Beris P: Recombinant human erythropoietin as adjuvant treatment for autologous blood donation in elective surgery with large blood needs ( or = 5 units): A randomized study. Transfusion 1997; 37:708-14
50. Faris PM, Ritter MA, Abels RI: The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am 1996; 78:62-72
51. Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P, Wheeler SL, Lau CY: Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med 2000; 133:845-54
52. G oodnough LT, Price TH, Friedman KD, Johnston M, Ciavarella D, Khan N, Sacher R, Vogler WR, Wissel M, Abels RI: A phase III trial of recombinant human erythropoietin therapy in non-anemic orthopedic patients subjected to aggressive removal of blood for autologous use: Dose, response, toxicity, and efficacy. Transfusion 1994; 34:66-71
53. H ayashi J, Kumon K, Takanashi S, Kawashima Y, Eguchi S, Takaku F, Yamamura H: Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: A double-blind, multicenter trial in Japan. Transfusion 1994; 34:142-6
54. Kettelhack C, Hones C, Messinger D, Schlag PM: Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg 1998; 85:63-67
55. Kosmadakis N, Messaris E, Maris A, Katsaragakis S, Leandros E, Konstadoulakis MM, Androulakis G: Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: Prospective randomized double-blind study. Ann Surg 2003; 237:417-21
56. Mercuriali F, Inghilleri G, Biffi E, Colotti MT, Vinci A, Oriani G: Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: A randomized, double-blind, placebo-controlled, dose-ranging study. Acta Haematol 1998; 100:69-76
57. Price TH, Goodnough LT, Vogler W, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI: The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter, randomized, double-blind, controlled trial. Transfusion 1996; 36:29-36
58. Qvist N, Boesby S, Wolff B, Hansen CP: Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: Reduced need for blood transfusions in patients undergoing colorectal surgery-prospective double-blind placebo-controlled study. 1999; 23:30-5
59. S cott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH : The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: A prospective, randomized, placebo-controlled study. Laryngoscope 2002; 112(7 pt 1):1221-9
60. S hapiro GS, Boachie-Adjei O, Dhawlikar SH, Maier LS : The use of Epoetin alfa in complex spine deformity surgery. Spine (Phila Pa 1976) 2002; 27:2067-71
61. S owade O, Warnke H, Scigalla P, Sowade B, Franke W, Messinger D, Gross J: Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997; 89:411-8
62. Walpoth B, Galliker B, Spirig P, Haeberli A, Rosenmund A, Althaus U, Nydegger UE: Use of epoetin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery. Semin Hematol 1996; 33(2 suppl 2):75-6
63. Andrews CM, Lane DW, Bradley JG: Iron pre-load for major joint replacement. Transfus Med 1997; 7:281-6
64. G arrido-Martín P, Nassar-Mansur MI, de la Llana-Ducrós R, Virgos-Aller TM, Rodríguez Fortunez PM, Ávalos-Pinto R, Jimenez-Sosa A, Martínez-Sanz R: The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: A randomized clinical trial. Interact Cardiovasc Thorac Surg 2012; 15:1013-8
65. Weisbach V, Skoda P, Rippel R, Lauer G, Glaser A, Zingsem J, Zimmermann R, Eckstein R: Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: A randomized, controlled study. Transfusion 1999; 39:465-72
66. Dotan ZA, Mor Y, Leibovitch I, Varon D, Golomb J, Duvdevani M, Ramon J: The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol 2002; 168:610-3
67. Firanescu CE, Martens EJ, Schönberger JP, Soliman Hamad MA, van Straten AH: Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study. Eur J Cardiothorac Surg 2009; 36:856-62
68. Firanescu CE, Martens EJ, Schönberger JP, Soliman Hamad MA, van Straten AH: Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study. Eur J Cardiothorac Surg 2009; 36:856-62
69. S him JK, Choi YS, Oh YJ, Bang SO, Yoo KJ, Kwak YL : Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2007; 134:59-64
70. Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, Villar JC, Sigamani A, Biccard BM, Meyhoff CS, Parlow JL, Guyatt G, Robinson A, Garg AX, Rodseth RN, Botto F, Lurati Buse G, Xavier D, Chan MT, Tiboni M, Cook D, Kumar PA, Forget P, Malaga G, Fleischmann E, Amir M, Eikelboom J, Mizera R, Torres D, Wang CY, VanHelder T, Paniagua P, Berwanger O, Srinathan S, Graham M, Pasin L, Le Manach Y, Gao P, Pogue J, Whitlock R, Lamy A, Kearon C, Baigent C, Chow C, Pettit S, Chrolavicius S, Yusuf S; POISE-2 Investigators: Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014; 370:1494-503
71. O scarsson A, Gupta A, Fredrikson M, Järhult J, Nyström M, Pettersson E, Darvish B, Krook H, Swahn E, Eintrei C: To continue or discontinue aspirin in the perioperative period: A randomized, controlled clinical trial. Br J Anaesth 2010; 104:305-12
72. Avall A, Hyllner M, Bengtson JP, Carlsson L, Bengtsson A: Postoperative inflammatory response after autologous and allogeneic blood transfusion. Anesthesiology 1997; 87:511-6
73. Bouchard D, Marcheix B, Al-Shamary S, Vanden Eynden F, Demers P, Robitaille D, Pellerin M, Perrault LP, Carrier M: Preoperative autologous blood donation reduces the need for allogeneic blood products: a prospective randomized study. Can J Surg 2008; 51:422-7
74. Chen G, Zhang FJ, Gong M, Yan M: Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients. J Zhejiang Univ Sci B 2007; 8:560-5
75. H edström M, Flordal PA, Ahl T, Svensson J, Dalén N: Autologous blood transfusion in hip replacement. No effect on blood loss but less increase of plasminogen activator inhibitor in a randomized series of 80 patients. Acta Orthop Scand 1996; 67:317-20
76. H eiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, Dieterich HJ, Eissner HJ, Schildberg FW: Blood transfusion-modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12:1859-67
77. Kajikawa M, Nonami T, Kurokawa T, Hashimoto S, Harada A, Nakao A, Takagi H: Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: Use of recombinant human erythropoietin. Surgery 1994; 115:727-34
78. Capraro L, Kuitunen A, Salmenperä M, Kekomäki R: On-site coagulation monitoring does not affect hemostatic outcome after cardiac surgery. Acta Anaesthesiol Scand 2001; 45:200-6
79. Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV, Ereth MH: Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001; 94:773-81
80. Wong CJ, Vandervoort MK, Vandervoort SL, Donner A, Zou G, MacDonald JK, Freedman J, Karkouti K, MacDonald SJ, Feagan BG: A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Transfusion 2007; 47:832-41
81. Ak K, Isbir CS, Tetik S, Atalan N, Tekeli A, Aljodi M, Civelek A, Arsan S: Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: A prospective randomized study. J Card Surg 2009; 24:404-10
82. Royston D, von Kier S: Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86:575-8
83. S hore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA: Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88:312-9
84. S chaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S: Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. Br J Anaesth 2012; 109:376-81
85. Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, Radovancevic B, McAllister HA Jr, Cooley DA: Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: Effect on patient outcome. Transfusion 1999; 39:1070-7
86. Bush RL, Pevec WC, Holcroft JW: A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. Am J Surg 1997; 174:143-8
87. Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, Srinivas V, Menegus MA, Marroquin OC, Rao SV, Noveck H, Passano E, Hardison RM, Smitherman T, Vagaonescu T, Wimmer NJ, Williams DO: Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013; 165: 964-71.e1
88. Johnson RG, Thurer RL, Kruskall MS, Sirois C, Gervino EV, Critchlow J, Weintraub RM: Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 1992; 104:307-14
89. S o-Osman C, Nelissen R, Te Slaa R, Coene L, Brand R, Brand A: A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sang 2010; 98:56-64
90. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, Magaziner J, Merlino FE, Bunce G, McClelland B, Duff A, Noveck H: A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998; 38:522-9
91. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators: Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365:2453-62
92. G rover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Boralessa H, Brett S, Goldhill DR, Soni N: Silent myocardial ischaemia and haemoglobin concentration: A randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang 2006; 90:105-12
93. H ajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Leão WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NA, Auler JO Jr: Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304:1559-67
94. H arwin SF, Issa K, Naziri Q, Johnson AJ, Mont MA: Results of primary total knee arthroplasty in Jehovah's Witness patients. J Arthroplasty 2013; 28:49-55
95. Magner D, Ouellette JR, Lee JR, Colquhoun S, Lo S, Nissen NN: Pancreaticoduodenectomy after neoadjuvant therapy in a Jehovah's witness with locally advanced pancreatic cancer: Case report and approach to avoid transfusion. Am Surg 2006; 72:435-7
96. Pasic M, D'Ancona G, Unbehaun A, Hetzer R: Bloodless third complex heart operation in a Jehovah's Witness patient with extremely low preoperative haemoglobin level. Interact Cardiovasc Thorac Surg 2012; 14:692-3
97. Podestà A, Parodi E, Dottori V, Crivellari R, Passerone GC: Epoetin alpha in elective coronary and valve surgery in Jehovah's Witnesses patients. Experience in 45 patients. Minerva Cardioangiol 2002; 50:125-31
98. S toye A, Chapin JW, Botha J, Grant W: Bloodless liver transplantation in a Jehovah's Witness. Int Anesthesiol Clin 2011; 49:108-15
99. Vaislic CD, Dalibon N, Ponzio O, Ba M, Jugan E, Lagneau F, Abbas P, Olliver Y, Gaillard D, Baget F, Sportiche M, Chedid A, Chaoul G, Maribas P, Dupuy C, Robine B, Kasanin N, Michon H, Ruat JM, Habis M, Bouharaoua T: Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year experience. J Cardiothorac Surg 2012; 7:95
100. S immons JW, White CE, Eastridge BJ, Mace JE, Wade CE, Blackbourne LH : Impact of policy change on US Army combat transfusion practices. J Trauma 2010; 69(suppl 1):S75-80
101. Dexter F, Ledolter J, Davis E, Witkowski TA, Herman JH, Epstein RH: Systematic criteria for type and screen based on procedure's probability of erythrocyte transfusion. Anesthesiology 2012; 116:768-78
102. Frank SM, Rothschild JA, Masear CG, Rivers RJ, Merritt WT, Savage WJ, Ness PM: Optimizing preoperative blood ordering with data acquired from an anesthesia information management system. Anesthesiology 2013; 118:1286-97
103. Kajja I, Bimenya GS, Eindhoven GB, ten Duis HJ, Sibinga CT: Surgical blood order equation in femoral fracture surgery. Transfus Med 2011; 21:7-12
104. Karger R, Bornmann A, Kretschmer V: Limited utility of algorithms predicting blood transfusions. Blood Transfus 2013; 11:426-32
105. Krupp NL, Weinstein G, Chalian A, Berlin JA, Wolf P, Weber RS: Validation of a transfusion prediction model in head and neck cancer surgery. Arch Otolaryngol Head Neck Surg 2003; 129:1297-302
106. Mahadevan D, Challand C, Clarke A, Keenan J: Maximum surgical blood ordering schedules for revision lower limb arthroplasty. Arch Orthop Trauma Surg 2011; 131:663-7
107. Nuttall GA, Horlocker TT, Santrach PJ, Oliver WC Jr, Dekutoski MB, Bryant S: Use of the surgical blood order equation in spinal instrumentation and fusion surgery. Spine (Phila Pa 1976) 2000; 25:602-5
108. Palmer T, Wahr JA, O'Reilly M, Greenfield ML: Reducing unnecessary cross-matching: A patient-specific blood ordering system is more accurate in predicting who will receive a blood transfusion than the maximum blood ordering system. Anesth Analg 2003; 96:369-75
109. S ubramanian A, Sagar S, Kumar S, Agrawal D, Albert V, Misra MC: Maximum surgical blood ordering schedule in a tertiary trauma center in northern India: A proposal. J Emerg Trauma Shock 2012; 5:321-7
110. van Klei WA, Moons KG, Leyssius AT, Knape JT, Rutten CL, Grobbee DE: A reduction in type and screen: Preoperative prediction of RBC transfusions in surgery procedures with intermediate transfusion risks. Br J Anaesth 2001; 87:250-7
111. Nuttall GA, Santrach PJ, Oliver WC Jr, Ereth MH, Horlocker TT, Cabanela ME, Trousdale RT, Bryant S, Currie TW: A prospective randomized trial of the surgical blood order equation for ordering red cells for total hip arthroplasty patients. Transfusion 1998; 38:828-33
112. H anke AA, Joch C, Görlinger K: Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): A pharmacovigilance study. Br J Anaesth 2013; 110:764-72
113. S chick KS, Fertmann JM, Jauch KW, Hoffmann JN: Prothrombin complex concentrate in surgical patients: Retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 2009; 13:R191
114. Wong Y: Use of prothrombin complex concentrate for vitamin K antagonist reversal before surgical treatment of intracranial hemorrhage. Clin Med Insights Case Rep 2011; 4:1-6
115. Barnette RE, Wendling WW, Schweiger JW, Brister NW, Schartel SA, Chen D, Shuman CA, McClurken JB, Jeevanandam V: Intravenous vitamin K1 prior to orthotopic heart transplantation: Effects in vivo and in vitro. Acta Anaesthesiol Scand 1997; 41(1 pt 1):78-83
116. Amar D, Grant FM, Zhang H, Boland PJ, Leung DH, Healey JA: Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery. Anesthesiology 2003; 98:337-42
117. Daily PO, Lamphere JA, Dembitsky WP, Adamson RM, Dans NF: Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study. J Thorac Cardiovasc Surg 1994; 108:99-106
118. Dalmau A, Sabaté A, Acosta F, Garcia-Huete L, Koo M, Sansano T, Rafecas A, Figueras J, Jaurrieta E, Parrilla P: Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg 2000; 91:29-34
119. Florentino-Pineda I, Thompson GH, Poe-Kochert C, Huang RP, Haber LL, Blakemore LC: The effect of amicar on perioperative blood loss in idiopathic scoliosis: The results of a prospective, randomized double-blind study. Spine (Phila Pa 1 976) 2004; 29:233-8
120. H arley BJ, Beaupré LA, Jones CA, Cinats JG, Guenther CR: The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: A pilot study. Can J Surg 2002; 45:185-90
121. Kikura M, Levy JH, Tanaka KA, Ramsay JG: A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. J Am Coll Surg 2006; 202:216-22
122. Kluger R, Olive DJ, Stewart AB, Blyth CM: Epsilonaminocaproic acid in coronary artery bypass graft surgery: Preincision or postheparin? Anesthesiology 2003; 99:1263-9
123. Menichetti A, Tritapepe L, Ruvolo G, Speziale G, Cogliati A, Di Giovanni C, Pacilli M, Criniti A: Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: Aprotinin vs tranexamic acid vs epsilon aminocaproic acid. J Cardiovasc Surg (Torino) 1996; 37:401-7
124. Ray M, Hatcher S, Whitehouse SL, Crawford S, Crawford R: Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty-A prospective randomized double-blind placebo-controlled study. J Thromb Haemost 2005; 3:1421-7
125. T roianos CA, Sypula RW, Lucas DM, D'Amico F, Mathie TB, Desai M, Pasqual RT, Pellegrini RV, Newfeld ML: The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting. Anesthesiology 1999; 91:430-5
126. Camarasa MA, Ollé G, Serra-Prat M, Martín A, Sánchez M, Ricós P, Pérez A, Opisso L: Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: A randomized clinical trial. Br J Anaesth 2006; 96:576-82
127. Ahn SW, Shim JK, Youn YN, Song JW, Yang SY, Chung SC, Kwak YL : Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery. Circ J 2012; 76:96-101
128. Caglar GS, Tasci Y, Kayikcioglu F, Haberal A: Intravenous tranexamic acid use in myomectomy: A prospective randomized double-blind placebo controlled study. Eur J Obstet Gynecol Reprod Biol 2008; 137:227-31
129. Choi WS, Irwin MG, Samman N: The effect of tranexamic acid on blood loss during orthognathic surgery: A randomized controlled trial. J Oral Maxillofac Surg 2009; 67:125-33
130. Claeys MA, Vermeersch N, Haentjens P: Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 2007; 107:397-401
131. Coffey A, Pittmam J, Halbrook H, Fehrenbacher J, Beckman D, Hormuth D: The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: A doubleblind randomized trial. Am Surg 1995; 61:566-8
132. Crescenti A, Borghi G, Bignami E, Bertarelli G, Landoni G, Casiraghi GM, Briganti A, Montorsi F, Rigatti P, Zangrillo A: Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: Double blind, randomised, placebo controlled trial. BMJ 2011; 343:d5701
133. Dadure C, Sauter M, Bringuier S, Bigorre M, Raux O, Rochette A, Canaud N, Capdevila X: Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: A randomized double-blind study. Anesthesiology 2011; 114:856-61
134. E kbäck G, Axelsson K, Ryttberg L, Edlund B, Kjellberg J, Weckström J, Carlsson O, Schött U: Tranexamic acid reduces blood loss in total hip eplacement surgery. Anesth Analg 2000; 91:1124-30
135. G oobie SM, Meier PM, Pereira LM, McGowan FX, Prescilla RP, Scharp LA, Rogers GF, Proctor MR, Meara JG, Soriano SG, Zurakowski D, Sethna NF: Efficacy of tranexamic acid in pediatric craniosynostosis surgery: A double-blind, placebo-controlled trial. Anesthesiology 2011; 114:862-71
136. Jansen AJ, Andreica S, Claeys M, D'Haese J, Camu F, Jochmans K: Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 1999; 83:596-601
137. Katsaros D, Petricevic M, Snow NJ, Woodhall DD, Van Bergen R: Tranexamic acid reduces postbypass blood use: A double-blinded, prospective, randomized study of 210 patients. Ann Thorac Surg 1996; 61:1131-5
138. L emay E, Guay J, Côté C, Roy A: Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 2004; 51:31-7
139. Menichetti A, Tritapepe L, Ruvolo G, Speziale G, Cogliati A, Di Giovanni C, Pacilli M, Criniti A: Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: Aprotinin vs tranexamic acid vs epsilon aminocaproic acid. J Cardiovasc Surg (Torino) 1996; 37:401-7
140. Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM: A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 2001; 93:82-7
141. O rpen NM, Little C, Walker G, Crawfurd EJ: Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: A prospective randomised controlled trial of 29 patients. Knee 2006; 13:106-10
142. Pleym H, Stenseth R, Wahba A, Bjella L, Karevold A, Dale O: Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesth Analg 2003; 96:923-8
143. T aghaddomi RJ, Mirzaee A, Attar AS, Shirdel A: Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2009; 23:312-5
144. Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, Brucek P, Maly M: Fibrinolytic inhibitors in off-pump coronary surgery: A prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). Eur J Cardiothorac Surg 2005; 28:563-8
145. Wei M, Jian K, Guo Z, Wang L, Jiang D, Zhang L, Tarkka M: Tranexamic acid reduces postoperative bleeding in offpump coronary artery bypass grafting. Scand Cardiovasc J 2006; 40:105-9
146. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, Syed KA, Muhammad Ovais Hasan S, De Silva Y, Chung F: Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: A randomized, controlled trial. J Bone Joint Surg Am 2010; 92:2503-13
147. Wu CC, Ho WM, Cheng SB, Yeh DC, Wen MC, Liu TJ, P'eng FK: Perioperative parenteral tranexamic acid in liver tumor resection: A prospective randomized trial toward a "blood transfusion"-free hepatectomy. Ann Surg 2006; 243:173-80
148. Y amasaki S, Masuhara K, Fuji T: Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop 2004; 28:69-73
149. Zabeeda D, Medalion B, Sverdlov M, Ezra S, Schachner A, Ezri T, Cohen AJ: Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization. Ann Thorac Surg 2002; 74:733-8
150. Zufferey PJ, Miquet M, Quenet S, Martin P, Adam P, Albaladejo P, Mismetti P, Molliex S; tranexamic acid in hipfracture surgery (THI F) study: Tranexamic acid in hip fracture surgery: A randomized controlled trial. Br J Anaesth 2010; 104:23-30
151. Andreasen JJ, Nielsen C: Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. Eur J Cardiothorac Surg 2004; 26:311-7
152. Casati V, Sandrelli L, Speziali G, Calori G, Grasso MA, Spagnolo S: Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 2002; 123:1084-91
153. Dryden PJ, O'Connor JP, Jamieson WR, Reid I, Ansley D, Sadeghi H, Burr LH, Munro AI, Merrick PM: Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery. Can J Anaesth 1997; 44:934-41
154. H ardy JF, Bélisle S, Dupont C, Harel F, Robitaille D, Roy M, Gagnon L: Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization. Ann Thorac Surg 1998; 65:371-6
155. Jares M, Vanek T, Straka Z, Brucek P: Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting. J Cardiovasc Surg (Torino) 2003; 44:205-8
156. Karski JM, Teasdale SJ, Norman P, Carroll J, VanKessel K, Wong P, Glynn MF: Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Doubleblind, randomized clinical trial. J Thorac Cardiovasc Surg 1995; 110:835-42
157. Penta de Peppo A, Pierri MD, Scafuri A, De Paulis R, Colantuono G, Caprara E, Tomai F, Chiariello L: Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs. Tex Heart Inst J 1995; 22:231-6
158. Benoni G, Fredin H: Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: A prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 1996; 78:434-40
159. Benoni G, Lethagen S, Nilsson P, Fredin H: Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand 2000; 71:250-4
160. G ood L, Peterson E, Lisander B: Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 2003; 90:596-9
161. H iippala ST, Strid LJ, Wennerstrand MI, Arvela JV, Niemelä HM, Mäntylä SK, Kuisma RP, Ylinen JE: Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997; 84:839-44
162. H iippala S, Strid L, Wennerstrand M, Arvela V, Mäntylä S, Ylinen J, Niemelä H: Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 1995; 74:534-7
163. L in PC, Hsu CH, Huang CC, Chen WS, Wang JW: The bloodsaving effect of tranexamic acid in minimally invasive total knee replacement: Is an additional pre-operative injection effective? J Bone Joint Surg Br 2012; 94:932-6
164. Casati V, Bellotti F, Gerli C, Franco A, Oppizzi M, Cossolini M, Calori G, Benussi S, Alfieri O, Torri G: Tranexamic acid administration after cardiac surgery: A prospective, randomized, double-blind, placebo-controlled study. Anesthesiology 2001; 94:8-14
165. Bennett SR: Perioperative autologous blood transfusion in elective total hip prosthesis operations. Ann R Coll Surg Engl 1994; 76:95-8
166. Bennett J, Haynes S, Torella F, Grainger H, McCollum C: Acute normovolemic hemodilution in moderate blood loss surgery: A randomized controlled trial. Transfusion 2006; 46:1097-103
167. Boldt J, Weber A, Mailer K, Papsdorf M, Schuster P: Acute normovolaemic haemodilution vs controlled hypotension for reducing the use of allogeneic blood in patients undergoing radical prostatectomy. Br J Anaesth 1999; 82:170-4
168. Fischer M, Matsuo K, Gonen M, Grant F, Dematteo RP, D'Angelica MI, Mascarenhas J, Brennan MF, Allen PJ, Blumgart LH, Jarnagin WR: Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: Results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management. Ann Surg 2010; 252:952-8
169. Ford SM, Unsworth-White MJ, Aziz T, Tooze JA, van Besouw JP, Bevan DH, Treasure T: Platelet pheresis is not a useful adjunct to blood-sparing strategies in cardiac surgery. J Cardiothorac Vasc Anesth 2002; 16:321-9
170. G uo JR, Yu J, Jin XJ, Du JM, Guo W, Yuan XH: Effects of acute normovolemic hemodilution on perioperative coagulation and fibrinolysis in elderly patients undergoing hepatic carcinectomy. Chin Med Sci J 2010; 25:146-50
171. Jarnagin WR, Gonen M, Maithel SK, Fong Y, D'Angelica MI, Dematteo RP, Grant F, Wuest D, Kundu K, Blumgart LH, Fischer M: A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Ann Surg 2008; 248:360-9
172. Kahraman S, Altunkaya H, Celebioʇlu B, Kanbak M, Paşaoʇlu I, Erdem K: The effect of acute normovolemic hemodilution on homologous blood requirements and total estimated red blood cell volume lost. Acta Anaesthesiol Scand 1997; 41:614-7
173. Matot I, Scheinin O, Jurim O, Eid A: Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology 2002; 97:794-800
174. Menges T, Wagner RM, Welters I, Ruwoldt R, Boldt J, Hempelmann G: The role of the protein C-thrombomodulin system and fibrinolysis during cardiovascular surgery: Influence of acute preoperative plasmapheresis. J Cardiothorac Vasc Anesth 1996; 10:482-9
175. O lsfanger D, Fredman B, Goldstein B, Shapiro A, Jedeikin R: Acute normovolaemic haemodilution decreases postoperative allogeneic blood transfusion after total knee replacement. Br J Anaesth 1997; 79:317-21
176. Ramnath AN, Naber HR, de Boer A, Leusink JA: No benefit of intraoperative whole blood sequestration and autotransfusion during coronary artery bypass grafting: Results of a randomized clinical trial. J Thorac Cardiovasc Surg 2003; 125:1432-7
177. T riulzi DJ, Gilmor GD, Ness PM, Baumgartner WA, Schultheis LW: Efficacy of autologous fresh whole blood or platelet-rich plasma in adult cardiac surgery. Transfusion 1995; 35:627-34
178. Wajon P, Gibson J, Calcroft R, Hughes C, Thrift B: Intraoperative plateletpheresis and autologous platelet gel do not reduce chest tube drainage or allogeneic blood transfusion after reoperative coronary artery bypass graft. Anesth Analg 2001; 93:536-42
179. Blais RE, Hadjipavlou AG, Shulman G: Efficacy of autotransfusion in spine surgery: Comparison of autotransfusion alone and with hemodilution and apheresis. Spine (Phila Pa 1 976) 1996; 21:2795-800
180. Casati V, Speziali G, D'Alessandro C, Cianchi C, Antonietta Grasso M, Spagnolo S, Sandrelli L: Intraoperative low-volume acute normovolemic hemodilution in adult open-heart surgery. Anesthesiology 2002; 97:367-73
181. H elm RE, Klemperer JD, Rosengart TK, Gold JP, Peterson P, DeBois W, Altorki NK, Lang S, Thomas S, Isom OW, Krieger KH: Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding. Ann Thorac Surg 1996; 62:1431-41
182. H öhn L, Schweizer A, Licker M, Morel DR: Absence of beneficial effect of acute normovolemic hemodilution combined with aprotinin on allogeneic blood transfusion requirements in cardiac surgery. Anesthesiology 2002; 96:276-82
183. Kochamba GS, Pfeffer TA, Sintek CF, Khonsari S: Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass. Ann Thorac Surg 1996; 61:900-3
184. L icker M, Sierra J, Kalangos A, Panos A, Diaper J, Ellenberger C: Cardioprotective effects of acute normovolemic hemodilution in patients with severe aortic stenosis undergoing valve replacement. Transfusion 2007; 47:341-50
185. L isander B, Jonsson R, Nordwall A: Combination of bloodsaving methods decreases homologous blood requirements in scoliosis surgery. Anaesth Intensive Care 1996; 24:555-8
186. McGill N, O'Shaughnessy D, Pickering R, Herbertson M, Gill R: Mechanical methods of reducing blood transfusion in cardiac surgery: Randomised controlled trial. BMJ 2002; 324:1299
187. S hulman G, Solanki DR, Hadjipavlou A: Augmented autologous transfusions in major reconstructive spine surgery. J Clin Apher 1998; 13:62-8
188. Wolowczyk L, Nevin M, Smith FC, Baird RN, Lamont PM: Haemodilutional effect of standard fluid management limits the effectiveness of acute normovolaemic haemodilution in AAA surgery-results of a pilot trial. Eur J Vasc Endovasc Surg 2003; 26:405-11
189. Andreasen JJ, Dethlefsen C, Modrau IS, Baech J, Schonheyder HC, Moeller JK, Johnsen SP; North-West Denmark Transfusion Study Group: Storage time of allogeneic red blood cells is associated with risk of severe postoperative infection after coronary artery bypass grafting. Eur J Cardiothorac Surg 2011; 39:329-34
190. Cata JP, Klein EA, Hoeltge GA, Dalton JE, Mascha E, O'Hara J, Russell A, Kurz A, Ben-Elihayhu S, Sessler DI: Blood storage duration and biochemical recurrence of cancer after radical prostatectomy. Mayo Clin Proc 2011; 86:120-7
191. Chen J, Singhapricha T, Memarzadeh M, Ziman A, Yuan S, Hu KQ, Steadman RH, Busuttil RW, Xia VW: Storage age of transfused red blood cells during liver transplantation and its intraoperative and postoperative effects. World J Surg 2012; 36:2436-42
192. E dgren G, Kamper-Jørgensen M, Eloranta S, Rostgaard K, Custer B, Ullum H, Murphy EL, Busch MP, Reilly M, Melbye M, Hjalgrim H, Nyrén O: Duration of red blood cell storage and survival of transfused patients (CME). Transfusion 2010; 50:1185-95
193. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH : Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358:1229-39
194. McKenny M, Ryan T, Tate H, Graham B, Young VK, Dowd N: Age of transfused blood is not associated with increased postoperative adverse outcome after cardiac surgery. Br J Anaesth 2011; 106:643-9
195. Mynster T, Nielsen HJ: The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Danish RANX05 Colorectal Cancer Study Group. Scand J Gastroenterol 2000; 35:212-7
196. Vamvakas EC, Carven JH: Length of storage of transfused red cells and postoperative morbidity in patients undergoing coronary artery bypass graft surgery. Transfusion 2000; 40:101-9
197. van de Watering L, Lorinser J, Versteegh M, Westendord R, Brand A: Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion 2006; 46:1712-8
198. van Straten AH, Soliman Hamad MA, van Zundert AA, Martens EJ, ter Woorst JF, de Wolf AM, Scharnhorst V: Effect of duration of red blood cell storage on early and late mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2011; 141:231-7
199. Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, Brand R, van Oers MH, Brand A: Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004; 109:2755-60
200. H oubiers JG, Brand A, van de Watering LM, Hermans J, Verwey PJ, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes T, de Vries JE: Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coatdepleted blood in surgery for colorectal cancer. Lancet 1994; 344:573-8
201. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Møller-Nielsen C, Hanberg-Sørensen F, Hokland M: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79:513-6
202. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N: Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348:841-5
203. T artter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M: Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998; 176:462-6
204. T itlestad IL, Ebbesen LS, Ainsworth AP, Lillevang ST, Qvist N, Georgsen J: Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized study. Int J Colorectal Dis 2001; 16:147-53
205. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer H, Harvey MS, Huysmans HA, Brand A: Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial. Circulation 1998; 97:562-8
206. Clagett GP, Valentine RJ, Jackson MR, Mathison C, Kakish HB, Bengtson TD: A randomized trial of intraoperative autotransfusion during aortic surgery. J Vasc Surg 1999; 29:22-30
207. Daane CR, Golab HD, Meeder JH, Wijers MJ, Bogers AJ: Processing and transfusion of residual cardiopulmonary bypass volume: Effects on haemostasis, complement activation, postoperative blood loss and transfusion volume. Perfusion 2003; 18:115-21
208. Damgaard S, Steinbrüchel DA: Autotransfusion with cell saver for off-pump coronary artery bypass surgery: A randomized trial. Scand Cardiovasc J 2006; 40:194-8
209. E kbäck G, Schött U, Axelsson K, Carlberg M: Perioperative autotransfusion and functional coagulation analysis in total hip replacement. Acta Anaesthesiol Scand 1995; 39:390-5
210. G oel P, Pannu H, Mohan D, Arora R: Efficacy of cell saver in reducing homologous blood transfusions during OPCAB surgery: A prospective randomized trial. Transfus Med 2007; 17:285-9
211. L aub GW, Dharan M, Riebman JB, Chen C, Moore R, Bailey BM, Fernandez J, Adkins MS, Anderson W, McGrath LB: The impact of intraoperative autotransfusion on cardiac surgery. A prospective randomized double-blind study. Chest 1993; 104:686-9
212. McGill N, O'Shaughnessy D, Pickering R, Herbertson M, Gill R: Mechanical methods of reducing blood transfusion in cardiac surgery: Randomised controlled trial. BMJ 2002; 324:1299
213. Mercer KG, Spark JI, Berridge DC, Kent PJ, Scott DJ: Randomized clinical trial of intraoperative autotransfusion in surgery for abdominal aortic aneurysm. Br J Surg 2004; 91:1443-8
214. Murphy GJ, Rogers CS, Lansdowne WB, Channon I, Alwair H, Cohen A, Caputo M, Angelini GD: Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: A randomized trial. J Thorac Cardiovasc Surg 2005; 130:20-8
215. Niranjan G, Asimakopoulos G, Karagounis A, Cockerill G, Thompson M, Chandrasekaran V: Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on-versus off-cardiopulmonary bypass: A randomised trial. Eur J Cardiothorac Surg 2006; 30:271-7
216. Rainaldi MP, Tazzari PL, Scagliarini G, Borghi B, Conte R: Blood salvage during caesarean section. Br J Anaesth 1998; 80:195-8
217. S park JI, Chetter IC, Kester RC, Scott DJ: Allogeneic versus autologous blood during abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 1997; 14:482-6
218. Sarkanović ML, Gvozdenović L, Savić D, Ilić MP, Jovanović G: Autologous blood transfusion in total knee replacement surgery. Vojnosanit Pregl 2013; 70:274-8
219. S henolikar A, Wareham K, Newington D, Thomas D, Hughes J, Downes M: Cell salvage auto transfusion in total knee replacement surgery. Transfus Med 1997; 7:277-80
220. T homas D, Wareham K, Cohen D, Hutchings H: Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 2001; 86:669-73
221. Nuttall GA, Oliver WC Jr, Beynen FM, Dull JJ, Murray MJ, Nichols WL: Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993; 7:402-9
222. Williams GD, Bratton SL, Riley EC, Ramamoorthy C: Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1999; 13:398-404
223. Wang SC, Shieh JF, Chang KY, Chu YC, Liu CS, Loong CC, Chan KH, Mandell S, Tsou MY: Thromboelastographyguided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: Randomized clinical trial. Transplant Proc 2010; 42:2590-3
224. T rzebicki J, Flakiewicz E, Kosieradzki M, Blaszczyk B, Kołacz M, Jureczko L, Pacholczyk M, Chmura A, Lagiewska B, Lisik W, Wasiak D, Kosson D, Kwiatkowski A, Lazowski T: The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products. Ann Transplant 2010; 15:19-24
225. Davidson SJ, McGrowder D, Roughton M, Kelleher AA: Can ROTE M thromboelastometry predict postoperative bleeding after cardiac surgery? J Cardiothorac Vasc Anesth 2008; 22:655-61
226. Reinhöfer M, Brauer M, Franke U, Barz D, Marx G, Lösche W: The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008; 19:212-9
227. Andreasen JB, Hvas AM, Christiansen K, Ravn HB: Can RoTE M® analysis be applied for haemostatic monitoring in paediatric congenital heart surgery? Cardiol Young 2011; 21:684-91
228. H aas T, Spielmann N, Mauch J, Madjdpour C, Speer O, Schmugge M, Weiss M: Comparison of thromboelastometry (ROTE M® ) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012; 108:36-41
229. H erbstreit F, Winter EM, Peters J, Hartmann M: Monitoring of haemostasis in liver transplantation: Comparison of laboratory based and point of care tests. Anaesthesia 2010; 65:44-9
230. O gawa S, Szlam F, Chen EP, Nishimura T, Kim H, Roback JD, Levy JH, Tanaka KA: A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 2012; 52:14-22
231. O swald E, Stalzer B, Heitz E, Weiss M, Schmugge M, Strasak A, Innerhofer P, Haas T: Thromboelastometry (ROTE M) in children: Age-related reference ranges and correlations with standard coagulation tests. Br J Anaesth 2010; 105:827-35
232. S tancheva A, Spassov L, Tzatchev K: Correlation between rotation thrombelastometry ROTE M analysis and standard haemostatic parameters during liver transplantation. Clin Lab 2011; 57:407-13
233. Chelemer SB, Prato BS, Cox PM Jr, O'Connor GT, Morton JR: Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 2002; 73:138-42
234. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH : Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34:1608-16
235. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD: Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116:2544-52
236. S reeram GM, Welsby IJ, Sharma AD, Phillips-Bute B, Smith PK, Slaughter TF: Infectious complications after cardiac surgery: Lack of association with fresh frozen plasma or platelet transfusions. J Cardiothorac Vasc Anesth 2005; 19:430-4
237. Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A: Transfusion-related acute lung injury due to HL A-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 1996; 93:707-13
238. Chung YT, Wu YC, Chen YH : Postoperative pulmonary edema, transfusion-related?-A case report. Acta Anaesthesiol Sin 2003; 41:43-6
239. Y asuda H, Ohto H, Yamaguchi O, Sakuma S, Suzuki T, Mita M, Tsuneyama H, Uchikawa M: Three episodes of delayed hemolytic transfusion reactions due to multiple red cell antibodies, anti-Di, anti-Jk and anti-E. Transfus Sci 2000; 23:107-12
240. Consten EC, Henny CP, Eijsman L, Dongelmans DA, van Oers MH: The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified. J Thorac Cardiovasc Surg 1996; 112:162-7
241. Wilhelmi M, Franke U, Cohnert T, Weber P, Kaukemüller J, Fischer S, Wahlers T, Haverich A: Coronary artery bypass grafting surgery without the routine application of blood products: Is it feasible? Eur J Cardiothorac Surg 2001; 19:657-61
242. Casas JI, Zuazu-Jausoro I, Mateo J, Oliver A, Litvan H, Muniz-Diaz E, Aris A, Caralps JM, Fontcuberta J: Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double-blind placebo-controlled study. J Thorac Cardiovasc Surg 1995; 110:1107-17
243. Despotis GJ, Levine V, Saleem R, Spitznagel E, Joist JH: Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: A randomised controlled trial. Lancet 1999; 354:106-10
244. Karnezis TA, Stulberg SD, Wixson RL, Reilly P: The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double-blind randomized trial. J Bone Joint Surg Am 1994; 76:1545-50
245. Pleym H, Stenseth R, Wahba A, Bjella L, Tromsdal A, Karevold A, Dale O: Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesth Analg 2004; 98:578-84
246. S heridan DP, Card RT, Pinilla JC, Harding SM, Thomson DJ, Gauthier L, Drotar D: Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction. Can J Surg 1994; 37:33-6
247. T emeck BK, Bachenheimer LC, Katz NM, Coughlin SS, Wallace RB: Desmopressin acetate in cardiac surgery: A double-blind, randomized study. South Med J 1994; 87:611-5
248. Wong AY, Irwin MG, Hui TW, Fung SK, Fan ST, Ma ES : Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Can J Anaesth 2003; 50:14-20
249. Ray MJ, Hales MM, Brown L, O'Brien MF, Stafford EG : Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit. Ann Thorac Surg 2001; 72:521-6
250. Codispoti M, Mankad PS: Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: Randomised controlled trial. Eur J Cardiothorac Surg 2002; 22:200-5
251. Figueras J, Llado L, Miro M, Ramos E, Torras J, Fabregat J, Serrano T: Application of fibrin glue sealant after hepatectomy does not seem justified: Results of a randomized study in 300 patients. Ann Surg 2007; 245:536-42
252. Jackson MR, Gillespie DL, Longenecker EG, Goff JM, Fiala LA, O'Donnell SD, Gomperts ED, Navalta LA, Hestlow T, Alving BM: Hemostatic efficacy of fibrin sealant (human) on expanded poly-tetrafluoroethylene carotid patch angioplasty: A randomized clinical trial. J Vasc Surg 1999; 30:461-6
253. Kjaergard HK, Trumbull HR: Vivostat system autologous fibrin sealant: Preliminary study in elective coronary bypass grafting. Ann Thorac Surg 1998; 66:482-6
254. Kluba T, Fiedler K, Kunze B, Ipach I, Suckel A: Fibrin sealants in orthopaedic surgery: Practical experiences derived from use of QUIXIL ® in total knee arthroplasty. Arch Orthop Trauma Surg 2012; 132:1147-52
255. L evy O, Martinowitz U, Oran A, Tauber C, Horoszowski H: The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 1999; 81:1580-8
256. Mawatari M, Higo T, Tsutsumi Y, Shigematsu M, Hotokebuchi T: Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: A prospective randomised study of 100 cases. J Orthop Surg (Hong Kong) 2006; 14:117-21
257. Notarnicola A, Moretti L, Martucci A, Spinarelli A, Tafuri S, Pesce V, Moretti B: Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty. Blood Coagul Fibrinolysis 2012; 23:278-84
258. Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, Hiebert C, Hess P, Joyce L, Bergsland J: Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 1989; 97:194-203
259. S abatini L, Trecci A, Imarisio D, Uslenghi MD, Bianco G, Scagnelli R: Fibrin tissue adhesive reduces postoperative blood loss in total knee arthroplasty. J Orthop Traumatol 2012; 13:145-51
260. Wang GJ, Goldthwaite CA Jr, Burks S, Crawford R, Spotnitz WD; Orthopaedic Investigators Group: Fibrin sealant reduces perioperative blood loss in total hip replacement. J Long Term Eff Med Implants 2003; 13:399-411
261. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, Mayers SL, Spotnitz WD: Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: A brief note on a randomized prospective trial. J Bone Joint Surg Am 2001; 83-A:1503-5
262. Chapman WC, Clavien PA, Fung J, Khanna A, Bonham A: Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: Results of a randomized controlled trial. Arch Surg 2000; 135:1200-4
263. Mathiasen RA, Cruz RM: Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy. Otolaryngol Head Neck Surg 2004; 131:601-5
264. Powell DM, Chang E, Farrior EH : Recovery from deepplane rhytidectomy following unilateral wound treatment with autologous platelet gel: A pilot study. Arch Facial Plast Surg 2001; 3:245-50
265. Bhardwaj M, Bunsell R: Beriplex P/N: An alternative to fresh frozen plasma in severe haemorrhage. Anaesthesia 2007; 62:832-4
266. Bruce D, Nokes TJ: Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: Experience in a large tertiary hospital. Crit Care 2008; 12:R105
267. L orenz R, Kienast J, Otto U, Kiehl M, Schreiter D, Haertel S, Barthels M: Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: A prospective clinical study. Blood Coagul Fibrinolysis 2007; 18:565-70
268. S tuklis RG, O'Shaughnessy DF, Ohri SK: Novel approach to bleeding in patients undergoing cardiac surgery with liver dysfunction. Eur J Cardiothorac Surg 2001; 19:219-20
269. Diprose P, Herbertson MJ, O'Shaughnessy D, Gill RS: Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: Randomized double-blind placebocontrolled pilot study. Br J Anaesth 2005; 95:596-602
270. Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, Büller HR, Levi M: Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A doubleblind placebo-controlled randomised trial. Lancet 2003; 361:201-5
271. Johansson PI, Eriksen K, Nielsen SL, Rojkjaer R, Alsbjørn B: Recombinant FVII a decreases perioperative blood transfusion requirement in burn patients undergoing excision and skin grafting-results of a single centre pilot study. Burns 2007; 33:435-40
272. L odge JP, Jonas S, Jones RM, Olausson M, Mir-Pallardo J, Soefelt S, Garcia-Valdecasas JC, McAlister V, Mirza DF; rFVII a OLT Study Group: Efficacy and safety of repeated perioperative doses of recombinant factor VII a in liver transplantation. Liver Transpl 2005; 11:973-9
273. L odge JP, Jonas S, Oussoultzoglou E, Malagó M, Jayr C, Cherqui D, Anthuber M, Mirza DF, Kuhlman L, Bechstein WO, Díaz JC, Tartiere J, Eyraud D, Fridberg M, Erhardtsen E, Mimoz O: Recombinant coagulation factor VII a in major liver resection: A randomized, placebo-controlled, doubleblind clinical trial. Anesthesiology 2005; 102:269-75
274. Raobaikady R, Redman J, Ball JA, Maloney G, Grounds RM: Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: A double-blind, randomized, placebo-controlled trial. Br J Anaesth 2005; 94:586-91
275. S hao YF, Yang JM, Chau GY, Sirivatanauksorn Y, Zhong SX, Erhardtsen E, Nivatvongs S, Lee PH: Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: A multicenter, randomized, double-blind, placebo-controlled trial. Am J Surg 2006; 191:245-9
276. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tønnesen E, Ingerslev J, Sørensen B: Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: A randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7:795-802
277. Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M: Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial. Anesthesiology 2013; 118:40-50